Recursion Pharmaceuticals is trading at $4.56, up 10.61%, with no fresh company-specific announcement or clear catalyst identified for the October 5, 2026 move.
- The company’s investor-relations releases show no October 5 announcement.
- Broader markets were mixed: the Nasdaq was up 0.71% and the S&P 500 up 0.35%, while the Dow was down 0.25%. That backdrop offers some support for growth stocks but does not establish a specific cause for the larger move.